Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.029 0.5
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.036 0.5
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.021 0.5
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.021 0.5
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.024 0.5
mRNA linifanib CTRPv2 pan-cancer AAC 0.023 0.5
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA PD-0332991 CCLE pan-cancer AAC -0.03 0.5
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.023 0.5
Download CSV